WINTON GROUP Ltd boosted its stake in shares of CorVel Co. (NASDAQ:CRVL - Free Report) by 757.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 32,628 shares of the business services provider's stock after purchasing an additional 28,824 shares during the period. WINTON GROUP Ltd owned approximately 0.06% of CorVel worth $3,630,000 at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of CRVL. Prudential Financial Inc. raised its stake in shares of CorVel by 176.9% in the fourth quarter. Prudential Financial Inc. now owns 90,468 shares of the business services provider's stock worth $10,065,000 after purchasing an additional 57,795 shares during the last quarter. Corebridge Financial Inc. increased its holdings in CorVel by 178.2% in the 4th quarter. Corebridge Financial Inc. now owns 14,187 shares of the business services provider's stock worth $1,578,000 after buying an additional 9,088 shares during the period. Vanguard Group Inc. raised its position in CorVel by 202.1% during the 4th quarter. Vanguard Group Inc. now owns 3,281,649 shares of the business services provider's stock worth $365,116,000 after buying an additional 2,195,466 shares during the last quarter. LPL Financial LLC lifted its stake in CorVel by 183.3% during the 4th quarter. LPL Financial LLC now owns 10,807 shares of the business services provider's stock valued at $1,202,000 after acquiring an additional 6,992 shares during the period. Finally, KLP Kapitalforvaltning AS purchased a new stake in shares of CorVel in the 4th quarter valued at $668,000. Institutional investors and hedge funds own 51.36% of the company's stock.
CorVel Stock Up 1.3 %
Shares of CRVL stock traded up $1.44 on Tuesday, hitting $113.41. The company had a trading volume of 119,475 shares, compared to its average volume of 111,880. The firm has a market cap of $5.82 billion, a P/E ratio of 66.71 and a beta of 1.06. CorVel Co. has a twelve month low of $76.20 and a twelve month high of $128.61. The company has a 50-day moving average price of $112.38 and a 200-day moving average price of $114.75.
CorVel (NASDAQ:CRVL - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.
Wall Street Analyst Weigh In
Separately, StockNews.com downgraded shares of CorVel from a "buy" rating to a "hold" rating in a research report on Thursday, March 13th.
Check Out Our Latest Report on CRVL
Insider Buying and Selling
In related news, Director Jeffrey J. Michael sold 10,477 shares of the company's stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $116.45, for a total value of $1,220,046.65. Following the completion of the transaction, the director now owns 568,310 shares of the company's stock, valued at approximately $66,179,699.50. This represents a 1.81 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Alan Hoops sold 10,200 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $116.39, for a total value of $1,187,178.00. Following the transaction, the director now owns 118,213 shares in the company, valued at $13,758,811.07. This represents a 7.94 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,200 shares of company stock valued at $3,824,115. Corporate insiders own 47.57% of the company's stock.
About CorVel
(
Free Report)
CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
See Also
Before you consider CorVel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CorVel wasn't on the list.
While CorVel currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
